RECRUITING

Computer Monitor vs Augmented Reality 3MDR for PTSD PTSD: A Randomized Controlled Trial

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a prospective randomized controlled trial comparing two ways of delivering Motion-assisted, Multi-modular Memory Desensitization and Reconsolidation (3MDR) therapy for posttraumatic stress disorder (PTSD). The study seeks 60 volunteers who have PTSD and are eligible for care in the Department of Defense healthcare system. There will be 10-14 therapy sessions that are 60-90 minutes long, about once a week, and symptoms will be assessed before and after the therapy as well as 3 and 6 months after completing therapy. 3MDR asks you to choose pictures and music that are integrated into a virtual reality environment. You will be walking on a treadmill throughout each therapy session, while the therapist stands next to the treadmill and asks you questions about the pictures you chose.

Official Title

Computer Monitor Versus Augmented Reality: Expanding 3MDR Therapy for PTSD

Quick Facts

Study Start:2023-04-30
Study Completion:2026-04-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05244564

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Service member, veteran, retiree, or DEERS-eligible dependent, male or female, at least 18 years or older
  2. * Diagnosis of PTSD, as confirmed by the CAPS-5
  3. * Able to ambulate with contact guard assistance or less, and walk unassisted on a treadmill, at a normal pace, for up to 90 minutes continuously
  1. * History of epilepsy or a seizure disorder, other than febrile seizures that occurred during childhood and have not recurred since
  2. * History of a psychotic disorder, bipolar disorder, or active suicidal or homicidal ideation
  3. * Use of benzodiazepines on a regular basis within the previous 30 days

Contacts and Locations

Study Contact

Hannah Attalah, BA
CONTACT
301-412-8187
care4ptsd@gmail.com
Michael Roy, MD, MPH
CONTACT
301-295-9601
michael.roy@usuhs.edu

Principal Investigator

Michael Roy, MD, MPH
PRINCIPAL_INVESTIGATOR
Unformed Services University

Study Locations (Sites)

Uniformed Services University
Bethesda, Maryland, 20814
United States

Collaborators and Investigators

Sponsor: Uniformed Services University of the Health Sciences

  • Michael Roy, MD, MPH, PRINCIPAL_INVESTIGATOR, Unformed Services University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-04-30
Study Completion Date2026-04-30

Study Record Updates

Study Start Date2023-04-30
Study Completion Date2026-04-30

Terms related to this study

Additional Relevant MeSH Terms

  • Stress Disorders, Post-Traumatic